Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses

S. Bhattacharya, W. C. Huangfu, G. Dong, J. Qian, D. P. Baker, J. Karar, C. Koumenis, J. A. Diehl, S. Y. Fuchs

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Viral and pharmacological inducers of protein kinase RNA-activated (PKR)-like ER kinase (PERK) were shown to accelerate the phosphorylation- dependent degradation of the IFNAR1 chain of the Type 1 interferon (IFN) receptor and to limit cell sensitivity to IFN. Here we report that hypoxia can elicit these effects in a PERK-dependent manner. The altered fate of IFNAR1 affected by signaling downstream of PERK depends on phosphorylation of eIF2α (eukaryotic translational initiation factor 2-α) and ensuing activation of p38α kinase. Activators of other eIF2α kinases such as PKR or GCN2 (general control nonrepressed-2) are also capable of eliminating IFNAR1 and blunting IFN responses. Modulation of constitutive PKR activity in human breast cancer cells stabilizes IFNAR1 and sensitizes these cells to IFNAR1-dependent anti-tumorigenic effects. Although downregulation of IFNAR1 and impaired IFNAR1 signaling can be elicited in response to amino-acid deficit, the knockdown of GCN2 in melanoma cells reverses these phenotypes. We propose that, in cancer cells and the tumor microenvironment, activation of diverse eIF2α kinases followed by IFNAR1 downregulation enables multiple cellular components of tumor tissue to evade the direct and indirect anti-tumorigenic effects of Type 1 IFN.

Original languageEnglish
Pages (from-to)4214-4221
Number of pages8
JournalOncogene
Volume32
Issue number36
DOIs
Publication statusPublished - Sep 2013
Externally publishedYes

Fingerprint

Interferon Type I
Phosphotransferases
Prokaryotic Initiation Factor-2
Eukaryotic Initiation Factor-2
eIF-2 Kinase
Interferons
Down-Regulation
Interferon alpha-beta Receptor
Phosphorylation
Cellular Microenvironment
Tumor Microenvironment
Human Activities
Melanoma
Neoplasms
Pharmacology
Breast Neoplasms
Phenotype
Amino Acids

Keywords

  • GCN2
  • IFNAR1
  • integrated stress response
  • interferon
  • PERK
  • tumor microenvironment

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Bhattacharya, S., Huangfu, W. C., Dong, G., Qian, J., Baker, D. P., Karar, J., ... Fuchs, S. Y. (2013). Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. Oncogene, 32(36), 4214-4221. https://doi.org/10.1038/onc.2012.439

Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. / Bhattacharya, S.; Huangfu, W. C.; Dong, G.; Qian, J.; Baker, D. P.; Karar, J.; Koumenis, C.; Diehl, J. A.; Fuchs, S. Y.

In: Oncogene, Vol. 32, No. 36, 09.2013, p. 4214-4221.

Research output: Contribution to journalArticle

Bhattacharya, S, Huangfu, WC, Dong, G, Qian, J, Baker, DP, Karar, J, Koumenis, C, Diehl, JA & Fuchs, SY 2013, 'Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses', Oncogene, vol. 32, no. 36, pp. 4214-4221. https://doi.org/10.1038/onc.2012.439
Bhattacharya, S. ; Huangfu, W. C. ; Dong, G. ; Qian, J. ; Baker, D. P. ; Karar, J. ; Koumenis, C. ; Diehl, J. A. ; Fuchs, S. Y. / Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. In: Oncogene. 2013 ; Vol. 32, No. 36. pp. 4214-4221.
@article{a6ed8f4d54e6418e90e0ab20f0c217e0,
title = "Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses",
abstract = "Viral and pharmacological inducers of protein kinase RNA-activated (PKR)-like ER kinase (PERK) were shown to accelerate the phosphorylation- dependent degradation of the IFNAR1 chain of the Type 1 interferon (IFN) receptor and to limit cell sensitivity to IFN. Here we report that hypoxia can elicit these effects in a PERK-dependent manner. The altered fate of IFNAR1 affected by signaling downstream of PERK depends on phosphorylation of eIF2α (eukaryotic translational initiation factor 2-α) and ensuing activation of p38α kinase. Activators of other eIF2α kinases such as PKR or GCN2 (general control nonrepressed-2) are also capable of eliminating IFNAR1 and blunting IFN responses. Modulation of constitutive PKR activity in human breast cancer cells stabilizes IFNAR1 and sensitizes these cells to IFNAR1-dependent anti-tumorigenic effects. Although downregulation of IFNAR1 and impaired IFNAR1 signaling can be elicited in response to amino-acid deficit, the knockdown of GCN2 in melanoma cells reverses these phenotypes. We propose that, in cancer cells and the tumor microenvironment, activation of diverse eIF2α kinases followed by IFNAR1 downregulation enables multiple cellular components of tumor tissue to evade the direct and indirect anti-tumorigenic effects of Type 1 IFN.",
keywords = "GCN2, IFNAR1, integrated stress response, interferon, PERK, tumor microenvironment",
author = "S. Bhattacharya and Huangfu, {W. C.} and G. Dong and J. Qian and Baker, {D. P.} and J. Karar and C. Koumenis and Diehl, {J. A.} and Fuchs, {S. Y.}",
year = "2013",
month = "9",
doi = "10.1038/onc.2012.439",
language = "English",
volume = "32",
pages = "4214--4221",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "36",

}

TY - JOUR

T1 - Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses

AU - Bhattacharya, S.

AU - Huangfu, W. C.

AU - Dong, G.

AU - Qian, J.

AU - Baker, D. P.

AU - Karar, J.

AU - Koumenis, C.

AU - Diehl, J. A.

AU - Fuchs, S. Y.

PY - 2013/9

Y1 - 2013/9

N2 - Viral and pharmacological inducers of protein kinase RNA-activated (PKR)-like ER kinase (PERK) were shown to accelerate the phosphorylation- dependent degradation of the IFNAR1 chain of the Type 1 interferon (IFN) receptor and to limit cell sensitivity to IFN. Here we report that hypoxia can elicit these effects in a PERK-dependent manner. The altered fate of IFNAR1 affected by signaling downstream of PERK depends on phosphorylation of eIF2α (eukaryotic translational initiation factor 2-α) and ensuing activation of p38α kinase. Activators of other eIF2α kinases such as PKR or GCN2 (general control nonrepressed-2) are also capable of eliminating IFNAR1 and blunting IFN responses. Modulation of constitutive PKR activity in human breast cancer cells stabilizes IFNAR1 and sensitizes these cells to IFNAR1-dependent anti-tumorigenic effects. Although downregulation of IFNAR1 and impaired IFNAR1 signaling can be elicited in response to amino-acid deficit, the knockdown of GCN2 in melanoma cells reverses these phenotypes. We propose that, in cancer cells and the tumor microenvironment, activation of diverse eIF2α kinases followed by IFNAR1 downregulation enables multiple cellular components of tumor tissue to evade the direct and indirect anti-tumorigenic effects of Type 1 IFN.

AB - Viral and pharmacological inducers of protein kinase RNA-activated (PKR)-like ER kinase (PERK) were shown to accelerate the phosphorylation- dependent degradation of the IFNAR1 chain of the Type 1 interferon (IFN) receptor and to limit cell sensitivity to IFN. Here we report that hypoxia can elicit these effects in a PERK-dependent manner. The altered fate of IFNAR1 affected by signaling downstream of PERK depends on phosphorylation of eIF2α (eukaryotic translational initiation factor 2-α) and ensuing activation of p38α kinase. Activators of other eIF2α kinases such as PKR or GCN2 (general control nonrepressed-2) are also capable of eliminating IFNAR1 and blunting IFN responses. Modulation of constitutive PKR activity in human breast cancer cells stabilizes IFNAR1 and sensitizes these cells to IFNAR1-dependent anti-tumorigenic effects. Although downregulation of IFNAR1 and impaired IFNAR1 signaling can be elicited in response to amino-acid deficit, the knockdown of GCN2 in melanoma cells reverses these phenotypes. We propose that, in cancer cells and the tumor microenvironment, activation of diverse eIF2α kinases followed by IFNAR1 downregulation enables multiple cellular components of tumor tissue to evade the direct and indirect anti-tumorigenic effects of Type 1 IFN.

KW - GCN2

KW - IFNAR1

KW - integrated stress response

KW - interferon

KW - PERK

KW - tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84883741732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883741732&partnerID=8YFLogxK

U2 - 10.1038/onc.2012.439

DO - 10.1038/onc.2012.439

M3 - Article

C2 - 23045272

AN - SCOPUS:84883741732

VL - 32

SP - 4214

EP - 4221

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 36

ER -